Basic Information
Vivera BioSciences focuses on developing a range of non-addictive drugs for indications including cardiovascular diseases, central nervous system disorders, and fluency disorders. The division's pipeline centers on the utilization of TABMELT®, a patient-centered alternative for oral and injectable drug delivery.